{"transactions":[{"id":2947450,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":144708,"kind":"person","name":"Bratica Joseph","position":1,"cik":"0001820070","reported_name":"Bratica Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-15T01:00:28.000Z","date":"2020-12-11","kind":"exercise","acquired":false,"shares":1115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":12285,"derivative":{"exercise_price":71.45,"exercise_date":"2019-03-05","expiration_date":"2028-03-05","underlying":"Common Stock","underlying_shares":1115},"source":{"system":"sec-edgar","filing":"0001209191-20-063355","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120063355/doc4.xml","form_type":"4"}},{"id":2947449,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":144708,"kind":"person","name":"Bratica Joseph","position":1,"cik":"0001820070","reported_name":"Bratica Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-15T01:00:28.000Z","date":"2020-12-11","kind":"sale","acquired":false,"shares":1115,"price":165,"value":183975.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":8140,"source":{"system":"sec-edgar","filing":"0001209191-20-063355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120063355/doc4.xml","form_type":"4"}},{"id":2947448,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":144708,"kind":"person","name":"Bratica Joseph","position":1,"cik":"0001820070","reported_name":"Bratica Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-15T01:00:28.000Z","date":"2020-12-11","kind":"exercise","acquired":true,"shares":1115,"price":71.45,"value":79666.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":9255,"source":{"system":"sec-edgar","filing":"0001209191-20-063355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120063355/doc4.xml","form_type":"4"}},{"id":2950768,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":144708,"kind":"person","name":"Bratica Joseph","position":1,"cik":"0001820070","reported_name":"Bratica Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-11T01:23:37.000Z","date":"2020-12-08","kind":"exercise","acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":4500,"derivative":{"exercise_price":29.6,"exercise_date":"2018-03-31","expiration_date":"2027-03-31","underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001209191-20-062807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120062807/doc4.xml","form_type":"4"}},{"id":2950767,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":144708,"kind":"person","name":"Bratica Joseph","position":1,"cik":"0001820070","reported_name":"Bratica Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-11T01:23:37.000Z","date":"2020-12-08","kind":"sale","acquired":false,"shares":1125,"price":160,"value":180000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":8140,"source":{"system":"sec-edgar","filing":"0001209191-20-062807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120062807/doc4.xml","form_type":"4"}},{"id":2950766,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":144708,"kind":"person","name":"Bratica Joseph","position":1,"cik":"0001820070","reported_name":"Bratica Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Financial Officer"}}],"security":"Common Stock","published_at":"2020-12-11T01:23:37.000Z","date":"2020-12-08","kind":"exercise","acquired":true,"shares":1125,"price":29.6,"value":33300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 308 shares purchased under the Company's registered Employee Stock Purchase Plan on August 31, 2020."}],"balance_after":9265,"source":{"system":"sec-edgar","filing":"0001209191-20-062807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120062807/doc4.xml","form_type":"4"}},{"id":3068435,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":144708,"kind":"person","name":"Bratica Joseph","position":1,"cik":"0001820070","reported_name":"Bratica Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-06T00:00:57.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":5625,"derivative":{"exercise_price":29.6,"exercise_date":"2018-03-31","expiration_date":"2027-03-31","underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001209191-20-045321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120045321/doc4.xml","form_type":"4"}},{"id":3068434,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":144708,"kind":"person","name":"Bratica Joseph","position":1,"cik":"0001820070","reported_name":"Bratica Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-06T00:00:57.000Z","date":"2020-08-03","kind":"sale","acquired":false,"shares":1125,"price":155,"value":174375.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":7832,"source":{"system":"sec-edgar","filing":"0001209191-20-045321","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120045321/doc4.xml","form_type":"4"}},{"id":3068433,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":144708,"kind":"person","name":"Bratica Joseph","position":1,"cik":"0001820070","reported_name":"Bratica Joseph","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-06T00:00:57.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":1125,"price":29.6,"value":33300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction."}],"balance_after":8957,"source":{"system":"sec-edgar","filing":"0001209191-20-045321","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120045321/doc4.xml","form_type":"4"}}]}